GTBP
Price
$3.20
Change
+$0.39 (+13.88%)
Updated
Dec 24 closing price
TRAW
Price
$11.61
Change
-$0.96 (-7.64%)
Updated
Dec 24 closing price
Ad is loading...

GTBP vs TRAW

Header iconGTBP vs TRAW Comparison
Open Charts GTBP vs TRAWBanner chart's image
GT Biopharma
Price$3.20
Change+$0.39 (+13.88%)
Volume$651K
CapitalizationN/A
Traws Pharma
Price$11.61
Change-$0.96 (-7.64%)
Volume$666.8K
CapitalizationN/A
GTBP vs TRAW Comparison Chart
Loading...
GTBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GTBP vs. TRAW commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTBP is a Hold and TRAW is a Hold.

COMPARISON
Comparison
Dec 25, 2024
Stock price -- (GTBP: $3.20 vs. TRAW: $11.61)
Brand notoriety: GTBP and TRAW are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GTBP: 131% vs. TRAW: 104%
Market capitalization -- GTBP: $7.15M vs. TRAW: $35.13M
GTBP [@Biotechnology] is valued at $7.15M. TRAW’s [@Biotechnology] market capitalization is $35.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GTBP’s FA Score shows that 0 FA rating(s) are green whileTRAW’s FA Score has 0 green FA rating(s).

  • GTBP’s FA Score: 0 green, 5 red.
  • TRAW’s FA Score: 0 green, 5 red.
According to our system of comparison, TRAW is a better buy in the long-term than GTBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GTBP’s TA Score shows that 7 TA indicator(s) are bullish while TRAW’s TA Score has 6 bullish TA indicator(s).

  • GTBP’s TA Score: 7 bullish, 3 bearish.
  • TRAW’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, GTBP is a better buy in the short-term than TRAW.

Price Growth

GTBP (@Biotechnology) experienced а +28.51% price change this week, while TRAW (@Biotechnology) price change was +128.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.88%. For the same industry, the average monthly price growth was -1.84%, and the average quarterly price growth was +2.99%.

Reported Earning Dates

GTBP is expected to report earnings on May 13, 2024.

TRAW is expected to report earnings on Nov 14, 2024.

Industries' Descriptions

@Biotechnology (-0.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRAW($35.1M) has a higher market cap than GTBP($7.15M). TRAW YTD gains are higher at: -37.715 vs. GTBP (-58.170). GTBP has higher annual earnings (EBITDA): -12.35M vs. TRAW (-24.08M). GTBP has more cash in the bank: 6.42M vs. TRAW (5.41M). TRAW has higher revenues than GTBP: TRAW (226K) vs GTBP (0).
GTBPTRAWGTBP / TRAW
Capitalization7.15M35.1M20%
EBITDA-12.35M-24.08M51%
Gain YTD-58.170-37.715154%
P/E RatioN/AN/A-
Revenue0226K-
Total Cash6.42M5.41M119%
Total Debt0N/A-
FUNDAMENTALS RATINGS
GTBP vs TRAW: Fundamental Ratings
GTBP
TRAW
OUTLOOK RATING
1..100
9733
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
39
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5735
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRAW's Valuation (39) in the Biotechnology industry is in the same range as GTBP (42) in the null industry. This means that TRAW’s stock grew similarly to GTBP’s over the last 12 months.

TRAW's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as GTBP (100) in the null industry. This means that TRAW’s stock grew similarly to GTBP’s over the last 12 months.

GTBP's SMR Rating (99) in the null industry is in the same range as TRAW (100) in the Biotechnology industry. This means that GTBP’s stock grew similarly to TRAW’s over the last 12 months.

TRAW's Price Growth Rating (35) in the Biotechnology industry is in the same range as GTBP (57) in the null industry. This means that TRAW’s stock grew similarly to GTBP’s over the last 12 months.

TRAW's P/E Growth Rating (100) in the Biotechnology industry is in the same range as GTBP (100) in the null industry. This means that TRAW’s stock grew similarly to GTBP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GTBPTRAW
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 6 days ago
86%
View a ticker or compare two or three
Ad is loading...
GTBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA462.2831.68
+7.36%
Tesla
BTC.X98676.0900003989.851600
+4.21%
Bitcoin cryptocurrency
AAPL258.202.93
+1.15%
Apple
SPY601.306.61
+1.11%
SPDR® S&P 500® ETF Trust
GME31.140.24
+0.78%
GameStop Corp

GTBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBP has been loosely correlated with BDRX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GTBP jumps, then BDRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTBP
1D Price
Change %
GTBP100%
+13.88%
BDRX - GTBP
37%
Loosely correlated
+12.29%
PTCT - GTBP
31%
Poorly correlated
-0.46%
TRAW - GTBP
27%
Poorly correlated
-7.64%
SCPX - GTBP
26%
Poorly correlated
+1.80%
DYN - GTBP
25%
Poorly correlated
+0.25%
More

TRAW and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRAW has been loosely correlated with SLGL. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if TRAW jumps, then SLGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRAW
1D Price
Change %
TRAW100%
-7.64%
SLGL - TRAW
63%
Loosely correlated
-40.62%
AVXL - TRAW
35%
Loosely correlated
-2.77%
RAPT - TRAW
34%
Loosely correlated
-0.57%
GLTO - TRAW
26%
Poorly correlated
+2.95%
GTBP - TRAW
26%
Poorly correlated
+13.88%
More